查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2023年至2028年女性用健康设备市场预测
市场调查报告书
商品编码
1410052

2023年至2028年女性用健康设备市场预测

Women's Health Devices Market - Forecasts from 2023 to 2028
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 143 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

女性用健康设备市场预计将从2021年的253.1亿美元成长到2028年的691.29亿美元，复合年增长率为15.44%。

预计女性用健康设备市场将在整个预测期内稳定成长。女性用健康设备专用用于追踪和治疗与女性相关的疾病，例如乳癌。卵巢、卵巢癌和妇科健康等众多健康问题和女性盛行率的上升是女性用健康设备市场的主要成长要素。此外，女性人口的增加和女性健康意识的增强预计将进一步推动女性用健康设备市场的发展。

多种疾病与女性有关

与女性相关的多种健康问题及其高盛行率是女性用的主要成长动力。女性比男性更容易感染爱滋病毒/爱滋病，影响 15 岁至 44 岁女性的健康问题中有三分之一是由性健康或生殖健康问题造成的。根据世界卫生组织报告，在非洲、中东和亚洲30个实行女性生殖器切割的国家中，到2023年，全球将有超过2亿女孩和妇女遭受女性生殖器切割。此外，据世界卫生组织称，2020年，几乎每两分钟就有一名孕产妇死亡，每天有近800名妇女死于与怀孕和分娩有关的本可避免的原因。

乳癌和卵巢癌发生率增加

乳癌发生率的增加及其对健康的负面影响预计将增加女性用健康设备市场。 2020年，全球有685,000名女性死亡，230万名女性被诊断出罹患乳癌。据世界卫生组织称，过去五年已有 780 万人被诊断出患有乳癌，到年终成为世界上最常见的癌症。其他女性特有的卵巢癌影响着广大女性群体，并证明了女性用健康设备的需求。根据 WCRF 的数据，卵巢癌是第 18 位最常见癌症，也是女性第 8 位最常见癌症。

老年女性人口增加

全球女性人口不断增加，对女性健康管理的需求不断增加，从而激活了女性用健康设备市场。例如，根据政府于 2019 年至 2021 年进行的第五次全国家庭健康调查 (NFHS)，印度目前首次实现每 1,000 名男性对应 1,020 名女性。此外，女性人口的老化正在推动女性用健康设备市场的发展，因为老化的女性人口更容易出现许多健康问题，例如糖尿病和卵巢癌。

市场机会

所有上述成长要素都为进入女性用健康设备市场提供了巨大的机会。此外，各种因素导致的女性健康投资需求的不断增加，也正在扩大女性用健康器材市场。例如，2023 年1 月举行的世界经济论坛会议估计，投资约3 亿美元用于针对女性的研究可带来130 亿美元的经济回报，从而降低医疗成本。被认为具有节省资金、改善医疗保健的潜力。生活质量，并多年来提高世界劳动力的生产力。此外，女性主导的医疗保健公司正在经历显着成长，例如 Maven Clinic，该公司于 2021 年获得了独角兽地位。以投资为重点的会议加上政府措施和意识提升宣传活动预计将对女性用健康设备市场产生积极影响。

预计北美将大幅成长

预计在预测期内，北美地区将占据女性用健康设备市场的主要份额。造成这一比例的因素包括美国女性乳癌患者数量的增加以及女性健康意识的增加。据美国癌症协会称，每年美国女性新发癌症病例中，乳癌占 30%（三分之一）。此外，同一消息来源估计，到 2023 年，美国女性将发现 297,790 例新的侵袭性乳癌病例。此外，根据美国劳工统计局的数据，2020年女性劳动参与率约为56%，女性收入占男性收入的百分比随着时间的推移而增加，使女性用更健康。

市场主要发展

2023年1月，Mavano在CES 2023上展示了女性用健康智慧环Evie，并于2022年10月完成临床试验。该公司计划寻求 FDA 批准首款消费者穿戴装置（同时也是医疗设备）。 2022 年 10 月，Solera Health推出了全球首个数位点解决方案的女性健康网路。我们将建立一个涵盖女性独特健康需求生命週期的网络，从骨盆底功能障碍到更年期。 2021 年 6 月，Organon 成立，成为同等规模下唯一致力于女性健康的全球公司。 Organon 的使命是提供有效的药物和解决方案，致力于帮助所有女性过上更健康的生活。

目录

第一章简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表

第二章调查方法

  • 调查资料
  • 调查过程

第三章执行摘要

  • 研究亮点

第四章市场动态

  • 市场驱动因素
  • 市场抑制因素
  • 波特五力分析
  • 产业价值链分析

第五章女性用健康设备市场：依应用分类

  • 介绍
  • 癌症
  • 骨质疏鬆症
  • 感染疾病
  • 子宫肌瘤
  • 停经后综合症
  • 怀孕
  • 女性节育手术
  • 其他的

第六章女性用健康设备市场：依最终用户分类

  • 介绍
  • 医院
  • 妇产科门诊
  • 诊断实验室
  • 门诊手术中心

第七章女性用健康设备市场：依地区

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 其他的
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 其他的
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 印尼
    • 泰国
    • 其他的

第八章竞争环境及分析

  • 主要企业及策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作

第九章 公司简介

  • Abbott Laboratories
  • GE Healthcare
  • Caldera Medical
  • MedGyn Products
  • F. Hoffmann-La Roche
  • Hologic
  • Koninklijke Philips
  • Siemens AG
简介目录
Product Code: KSI061615715

The women's health devices market is expected to grow at a CAGR of 15.44% from US$25.310 billion in 2021 to US$69.129 billion in 2028.

The women's health devices market is anticipated to grow at a steady pace throughout the forecast period. Women's health devices are exclusively designed to track and treat women-related illnesses such as breast cancer. Numerous health issues in women such as breast cancer, ovarian cancer, and gynecologic health, and their growing prevalence rate is a major growth driver in the women's health devices market. Moreover, the rising female population coupled with increased awareness about women's health is further expected to boost the women's health devices market.

Numerous Associated Illnesses in Women

Multiple women-associated health concerns and their higher prevalence rate is a major growth drivers in the women's health devices market. Women are more susceptible to HIV/AIDS than men and one-third of the health problems affecting women between the ages of 15 and 44 have a sexual or reproductive health component. In the 30 countries in Africa, the Middle East, and Asia where female genital mutilation (FGM) is practiced, more than 200 million girls and women worldwide have suffered FGM in 2023 as per the WHO reports. Moreover, a maternal fatality happened nearly every two minutes in 2020, and nearly 800 women per day passed away from pregnancy- and childbirth-related avoidable causes according to the WHO.

Growing Prevalence of Breast and Ovarian Cancer

The growing incidence of breast cancer and its adverse health effects is contemplated to augment the women's health devices market. In 2020, 685,000 women worldwide died and 2.3 million women were diagnosed with breast cancer. Breast cancer was the most common cancer in the world by the end of 2020, with 7.8 million women living with breast cancer who had received a diagnosis within the previous five years as per the WHO. The other women-specific ovarian cancer cases are affecting a huge women population indicating the need for women's health devices. According to the WCRF, the 18th most prevalent cancer overall and the 8th most common cancer worldwide in women is ovarian cancer.

Increased Elderly Female Population

The female population is rising worldwide and it is increasing the requirement of women's health care thereby boosting the women's health devices market. For instance, India had 1,020 women for every 1,000 men for the first time, according to the government's fifth National Family and Health Survey (NFHS), which was conducted between 2019 and 2021. Moreover, the older female population is more prone to numerous health issues such as diabetes, and ovarian cancer thus rising aging female population is propelling the women's health devices market. For instance, there will be around 604 million elderly women in the world by 2025 according to the NCBI.

Multiple Awareness Programs on Women's Health

The awareness programs and initiatives being taken by several organizations worldwide are improving women's health awareness thereby aiding the women's health devices market. Additionally, the Office of Human Research and Community Engagement (OHRCE), Clinical Research Branch (CRB), and National Institute of Environmental Health Sciences (NIEHS) are leading the Women's Health Awareness (WHA) Community Engagement Programme, an innovative environmental health research, and advocacy initiative in North Carolina.

Opportunities in the Market

All the growth factors mentioned provide an immense opportunity to enter the women's health devices market. Moreover, the increasing investment need in women's health being addressed by various factors is also extending the women's health devices market. For instance, at a conference of the World Economic Forum in January 2023, it was recognized that an estimated $300 million investment in women's-specific research might result in a $13 billion economic return and save money on healthcare, improve quality of life, and add years to the global workforce's productivity. Further, women-led healthcare companies are growing significantly, for example, Maven Clinic received a unicorn status in 2021. The investment focussed conferences coupled with government efforts and awareness campaigns are expected to positively impact the women's health devices market.

North America is projected to grow significantly

The North American region is projected to hold a significant share of the women's health devices market during the forecast period. Various factors attributed to such a share are increasing cases of breast cancer in US women, and increased awareness about women's health. Each year, breast cancer accounts for 30% (or 1 in 3) of all new cases of US female cancer as per the American Cancer Society. Moreover, around 297,790 new instances of invasive breast cancer are estimated to be detected in US women in 2023 as per the same source. Moreover, women's participation in the workforce was around 56% in 2020 as per the US Labour Statistics Bureau, and women's earnings as a proportion of men's earnings have increased over time enabling women to spend more on their health and thereby boosting the women's health devices market.

Women Health Devices Market Players

  • A leading provider of pharmaceutical diagnostics, digital solutions, and medical technology worldwide is GE Healthcare. Voluson Women's Health Ultrasound offered by the company is available in a wider range including Voluson™ Expert Series to encompass the most progressive imagining capabilities, and Voluson™ Performance for OB, GYN, and assisted reproductive medicine.
  • Caldera Medical is a US-based manufacturer of medical devices with a singular focus on the health of women and a goal of raising women's standards of living. Products offered by the company are Desara® for stress urinary incontinence, Vertessa® for sacrocolpopexy procedures, and Benesta® System for hard-to-reach fundal and corneal tissue.
  • Hologic is one of the leading women's health companies focusing on breast health, gynecologic health, sexual health, body composition, and skeletal health. 3Dimensions®Mammography System and 3DQuorum™ Imaging Technology are offered by the company for breast health.

Key Market Developments

  • In January 2023, Mavano showcased the women's health smart ring Evie at CES 2023 and completed a clinical trial in October 2022. The company is planning to seek FDA clearance which will make it the first consumer wearable that is also a medical device.
  • In October 2022, Solera Health launched a first-of-its-kind Women's Health Network of digital point solutions. It is built to build a network that spans the lifecycle of women's unique health needs from pelvic floor dysfunction to menopause.
  • In June 2021, Organon launched as the only global company of its size focused on women's health. With a mission to provide effective medicines and solutions, Organon is focused on enabling every woman to live a healthier life every day.

Segmentation:

By Application

  • Cancer
  • Osteoporosis
  • Infectious Disease
  • Uterine Fibroids
  • Post-menopausal Syndrome
  • Pregnancy
  • Female Sterilization
  • Other

By End-Users

  • Hospitals
  • Obstetrics & Gynecology Clinics
  • Diagnostic Laboratories
  • Ambulatory Surgical Centers

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

  • 2.1. Research Data
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Research Highlights

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Force Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. WOMEN'S HEALTH DEVICES MARKET, BY APPLICATION

  • 5.1. Introduction
  • 5.2. Cancer
  • 5.3. Osteoporosis
  • 5.4. Infectious Disease
  • 5.5. Uterine Fibroids
  • 5.6. Post-menopausal Syndrome
  • 5.7. Pregnancy
  • 5.8. Female Sterilization
  • 5.9. Other

6. WOMEN'S HEALTH DEVICES MARKET, BY END USERS

  • 6.1. Introduction
  • 6.2. Hospitals
  • 6.3. Obstetrics & Gynecology Clinics
  • 6.4. Diagnostic Laboratories
  • 6.5. Ambulatory Surgical Centers

7. WOMEN'S HEALTH DEVICES MARKET, BY GEOGRAPHY

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. United States
    • 7.2.2. Canada
    • 7.2.3. Mexico
  • 7.3. South America
    • 7.3.1. Brazil
    • 7.3.2. Argentina
    • 7.3.3. Others
  • 7.4. Europe
    • 7.4.1. United Kingdom
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Spain
    • 7.4.5. Others
  • 7.5. The Middle East and Africa
    • 7.5.1. Saudi Arabia
    • 7.5.2. UAE
    • 7.5.3. Israel
    • 7.5.4. Others
  • 7.6. Asia Pacific
    • 7.6.1. Japan
    • 7.6.2. China
    • 7.6.3. India
    • 7.6.4. South Korea
    • 7.6.5. Indonesia
    • 7.6.6. Thailand
    • 7.6.7. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Market Share Analysis
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations

9. COMPANY PROFILES

  • 9.1. Abbott Laboratories
  • 9.2. GE Healthcare
  • 9.3. Caldera Medical
  • 9.4. MedGyn Products
  • 9.5. F. Hoffmann-La Roche
  • 9.6. Hologic
  • 9.7. Koninklijke Philips
  • 9.8. Siemens AG